Literature DB >> 7924632

Chrono-neuroendocrinological aspects of physiological aging and senile dementia.

D Dori1, G Casale, S B Solerte, M Fioravanti, G Migliorati, G Cuzzoni, E Ferrari.   

Abstract

The circadian pattern of melatonin and cortisol secretion was evaluated in two groups of elderly subjects (aged 66-90 years), one with Alzheimer's type of multiinfarct dementia (n = 27) and the other without cognitive impairment (n = 16); 13 clinically healthy women aged 20 to 30 years were chosen as controls. All demented patients had severe mental impairment, corresponding to stage 6 of the Global Deterioration Scale. All subjects, either young or aged, were studied as in-patients and were well synchronized with respect to meal timing, diurnal activity and nocturnal rest. At the population mean cosinor analysis (Halberg, 1969) both melatonin and cortisol circadian rhythms reached statistical significance in the three groups of subjects. However, the melatonin circadian profile was clearly flattened in the two groups of elderly subjects by comparison with young controls, due to the selective impairment of melatonin nocturnal secretion. In both elderly groups, but particularly in demented patients, plasma cortisol levels were significantly higher by comparison to young controls, particularly at evening and night time. A significant direct relationship linked the subjects' age and the nadir values of plasma cortisol. Furthermore, the sensitivity of the hypothalamo-pituitary-adrenal axis to dexamethasone (DXM) suppression test (1 mg orally at 2300) was significantly reduced in both elderly groups, and especially in old demented patients, by comparison with young controls. Finally, plasma cortisol response to pulse i.v. injection of a small dose of synthetic corticotropin (Synacthen 2,500 ng) was significantly higher and more prolonged in old demented patients than in mentally healthy old subjects and in young controls.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7924632

Source DB:  PubMed          Journal:  Chronobiologia        ISSN: 0390-0037


  18 in total

Review 1.  Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes.

Authors:  Seithikurippu R Pandi-Perumal; Ahmed S BaHammam; Gregory M Brown; D Warren Spence; Vijay K Bharti; Charanjit Kaur; Rüdiger Hardeland; Daniel P Cardinali
Journal:  Neurotox Res       Date:  2012-06-28       Impact factor: 3.911

2.  MT2 melatonin receptor immunoreactivity in neurons is very high in the aged hippocampal formation in gerbils.

Authors:  Choong Hyun Lee; Jung Hoon Choi; Ki-Yeon Yoo; Ok Kyu Park; In Koo Hwang; Sang Guan You; Boo-Yong Lee; Il-Jun Kang; Moo-Ho Won
Journal:  Cell Mol Neurobiol       Date:  2009-09-02       Impact factor: 5.046

3.  Social network, cognitive function, and dementia incidence among elderly women.

Authors:  Valerie C Crooks; James Lubben; Diana B Petitti; Deborah Little; Vicki Chiu
Journal:  Am J Public Health       Date:  2008-05-29       Impact factor: 9.308

4.  Melatonin prevents death of neuroblastoma cells exposed to the Alzheimer amyloid peptide.

Authors:  M A Pappolla; M Sos; R A Omar; R J Bick; D L Hickson-Bick; R J Reiter; S Efthimiopoulos; N K Robakis
Journal:  J Neurosci       Date:  1997-03-01       Impact factor: 6.167

5.  Serum factors in older individuals change cellular clock properties.

Authors:  Lucia Pagani; Karen Schmitt; Fides Meier; Jan Izakovic; Konstanze Roemer; Antoine Viola; Christian Cajochen; Anna Wirz-Justice; Steven A Brown; Anne Eckert
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

Review 6.  Circadian rhythm sleep disorders: pathophysiology and potential approaches to management.

Authors:  N Zisapel
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 7.  Role of melatonin in neurodegenerative diseases.

Authors:  V Srinivasan; S R Pandi-Perumal; G Jm Maestroni; A I Esquifino; R Hardeland; D P Cardinali
Journal:  Neurotox Res       Date:  2005       Impact factor: 3.911

8.  Melatonin alters the metabolism of the beta-amyloid precursor protein in the neuroendocrine cell line PC12.

Authors:  W Song; D K Lahiri
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

9.  Effect of melatonin on changes in locomotor activity rhythm of Syrian hamsters injected with beta amyloid peptide 25-35 in the suprachiasmatic nuclei.

Authors:  Analía M Furio; Rodolfo A Cutrera; Víctor Castillo Thea; Santiago Pérez Lloret; Patricia Riccio; Roberto L Caccuri; Luis L Brusco; Daniel P Cardinali
Journal:  Cell Mol Neurobiol       Date:  2002-12       Impact factor: 5.046

10.  Melatonin attenuates hLRRK2-induced long-term memory deficit in a Drosophila model of Parkinson's disease.

Authors:  Dongzhi Ran; Baogang Xie; Zongjie Gan; Xicui Sun; Huaiyu Gu; Junqing Yang
Journal:  Biomed Rep       Date:  2018-07-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.